Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on: January 04,2024

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on:January 04,2024

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

February 2024Lara C. Pullen, PhDNew research reveals that patients with thrombocytopenia, thrombosis, and very high D-dimer levels could have platelet-activating vaccine-induced immune thrombocytopeni

Updated on: February 18,2024

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

February 2024Lara C. Pullen, PhDNew research reveals that patients with thrombocytopenia, thrombosis, and very high D-dimer levels could have platelet-activating vaccine-induced immune thrombocytopeni

Updated on:February 18,2024

Cancer Prevention Vaccines: A New Hope in the Fight Against Cancer

Updated on: November 06,2024

Cancer Prevention Vaccines: A New Hope in the Fight Against Cancer

Updated on:November 06,2024

Targeted screening could prevent one in six prostate cancer deaths

byUniversity College LondonMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Nearly one in six deaths from prostate

Updated on: December 23,2023

Targeted screening could prevent one in six prostate cancer deaths

byUniversity College LondonMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Nearly one in six deaths from prostate

Updated on:December 23,2023

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on: January 05,2024

Ultrasensitive blood test detects 'pan-cancer' biomarker

byMass General BrighamCirculating ORF1p levels in lung cancer patient cohort, as classified by (A) disease subtype, (B) gender, and (C) smoking status. Blue dashed line indicates the assay limit

Updated on:January 05,2024

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on: September 06,2024

Key discovery advances fight to reduce breast cancer recurrence

byDuke-NUS Medical SchoolLoss of Gα13 in ER+ breast cancer cells leads to increased cell growth and tumour development, suggesting that Gα13 may suppress tumours in this subtype of cancer. Credi

Updated on:September 06,2024

Mathematics supporting fresh theoretical approach in oncology

byUniversity of the Basque CountryMathematics, histopathology and genomics converge to confirm that highly aggressive clear cell renal cell carcinomas display low levels of intratumour heterogen

Updated on: January 26,2024

Mathematics supporting fresh theoretical approach in oncology

byUniversity of the Basque CountryMathematics, histopathology and genomics converge to confirm that highly aggressive clear cell renal cell carcinomas display low levels of intratumour heterogen

Updated on:January 26,2024

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on: December 22,2023

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on:December 22,2023

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Updated on: April 24,2024

Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation

by University of TsukubaCredit: Unsplash/CC0 Public DomainAllogeneic hematopoietic stem-cell transplantation (allo-HSCT) can cure hematopoietic diseases, such as acute myeloid leukemia. Cord bloo

Updated on:April 24,2024

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme

Updated on: December 22,2023

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme

Updated on:December 22,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on: December 25,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on:December 25,2023